MaxCyte Inc (MXCT) Ord USD0.01 (DI)
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
No change
194.00p
190.00p
253.00p
£111.15 million
194.00p
190.00p
175.00p
n/a
0.00p (0.00%) Previous:
0.00p
1,000
n/a
1,500
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2017 | 31/12/2016 |
|---|---|---|
| Revenue ($m) | 13.98 | 12.27 |
| Profit before tax ($m) | (9.92) | (3.35) |
| Adjusted EPS (¢): | (20.00) | (11.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
Broker recommendations for this stock are not available.
-
MaxCyte buddies-up with Gilead subsidiary
12 November 2018 12:50
-
MaxCyte signs cell platform deal with CRISPR and Casebia
14 March 2017 16:27
-
Notice of Full Year Results
26 March 2019 07:00
-
Director Dealings
19 March 2019 17:05
-
Grant of Options
5 March 2019 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.